Showing results (1271-1280 of 1,894) with videos related to
Sort By:
Pageof 190
Alzheimer Disease and Associated Disorders|January 1, 1995
Acetyl-L-carnitine in Alzheimer disease: a short-term study on CSF neurotransmitters and neuropeptidesG Bruno, S Scaccianoce, M Bonamini, et al.Alzheimer Disease and Associated Disorders|January 1, 1995
Reality orientation therapy in Alzheimer disease: useful or not? A controlled studyO Zanetti, G B Frisoni, D De Leo, et al.Alzheimer Disease and Associated Disorders|January 1, 1995
Validation of the NINCDS-ADRDA criteria regarding gait in the clinical diagnosis of Alzheimer disease. A clinicopathologic studyT A Ala, W H FreyAlzheimer Disease and Associated Disorders|October 13, 1998
A strategy for identifying immunosuppressive therapies for Alzheimer diseaseD GiulianAlzheimer Disease and Associated Disorders|October 15, 1998
Prevalence and subtypes of dementia in a rural Chinese populationH C Liu, J L Fuh, S J Wang, et al.Alzheimer Disease and Associated Disorders|October 15, 1998
Sensitivity and specificity of some neuropsychological markers of Alzheimer dementiaG Gainotti, C Marra, G Villa, et al.Alzheimer Disease and Associated Disorders|October 15, 1998
Age at onset and visuocognitive disturbances in Alzheimer diseaseM Fujimori, T Imamura, H Yamashita, et al.Alzheimer Disease and Associated Disorders|October 15, 1998
Slowing on quantitative spectral EEG is a marker for rate of subsequent cognitive and functional decline in early Alzheimer diseaseJ J Claus, V I Kwa, S Teunisse, et al.Alzheimer Disease and Associated Disorders|October 15, 1998
Role of familial factors in late-onset Alzheimer disease as a function of ageZ Wu, C Kinslow, K D Pettigrew, et al.Alzheimer Disease and Associated Disorders|October 15, 1998
Scintigraphy with 123I-serum amyloid P component in Alzheimer diseaseL B Lovat, A A O'Brien, S F Armstrong, et al.Pageof 190